A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin

• Ruijie Zhang,

  Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliations Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Xiaozhi Yang,

  Roles Investigation

  Affiliation Department of Medicinal Chemistry, College of Pharmacy, The University of Florida, Gainesville, Florida, United States of America

  ⨯
• Dana M. Roque,

  Roles Writing – review & editing

  Affiliation Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Chenglong Li ,

  Roles Supervision, Writing – review & editing

  * E-mail: lic@cop.ufl.edu (CL); JLin@som.umaryland.edu (JL)

  Affiliation Department of Medicinal Chemistry, College of Pharmacy, The University of Florida, Gainesville, Florida, United States of America

  ⨯
• Jiayuh Lin

  Roles Formal analysis, Funding acquisition, Methodology, Resources, Supervision, Writing – review & editing

  * E-mail: lic@cop.ufl.edu (CL); JLin@som.umaryland.edu (JL)

  Affiliation Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  https://orcid.org/0000-0002-0748-1041

  ⨯